 |
| Overview |
|
 |
Medegen Inc. is a leading provider of medical devices, components and contract manufacturing services to the healthcare, medical device and pharmaceutical manufacturer industries. The company specializes in developing technologies in infusion therapy centered on helping hospitals drive greater clinical performance and improved patient care.
|
Founded in 2001, the company provides clinically superior products and reliable, cost-effective services to the medical community through its three operating units Maximus, KippMed and Manufacturing Services.
Strategic investments have and will continue to be made in manufacturing capacity, technology, product innovation and marketing setting the course for the company's growth and market leadership.
The Manufacturing Services operating unit provides cost-effective contract manufacturing solutions to medical device manufacturers and pharmaceutical companies. Medegen's Manufacturing Services' comprehensive offering helps customers reduce their time to market. Services include product design and development; injection molding; process design and validation; and production, assembly and packaging of medical devices.
The Maximus operating unit develops, manufactures and markets needleless intravenous (IV) therapy products used by leading hospitals across the US. These products feature the company's patented valve technology, clinically proven to enhance patient outcomes by assisting in the prevention of bloodstream infections and catheter occlusions. Maximus is dedicated to providing quality, cost-effective products that meet clinicians' patient care needs, for safety and ease-of-use, as well as ensuring compliance with the needle free regulations.
KippMed manufactures and markets IV therapy components which support the products of leading IV therapy companies. KippMed is a leading supplier of components sold to OEMs.
Company History
In September 2006, the company sold its market leading Medical Products division to Medical Action Industries (NASDAQ:MDCI). Recognizing the need for innovation and better process in the infusion therapy products market, Medegen's executive team pursued strategic acquisition opportunities. In mid 2003, Medegen acquired KippGroup a leading supplier of IV Therapy components and in 2004, Medegen acquired Maximus Medical, a specialty IV therapy products company. With these acquisitions Medegen entered the highly innovative and growing market of infusion therapy.
Innovation Leader
Medegen is gaining recognition as a leader in IV therapy products due to the clinical performance of its products containing Tru-Swab technology. Tru-Swab technology gives clinicians the first swabable surface free of crevices, nooks and crannies that can harbor bacteria. All of Medegen's needleless valves feature Tru-Swab valve technology which provides a flat smooth surface allowing for thorough disinfection of the valve top prior to access. The design, which allows for the valve top to remain flat and smooth, is patented.
The company's leading MaxPlus valve also features Medegen's patented positive displacement technology which provides a bolus of fluid to clear the catheter tip upon disconnection from the device. Medegen's patented technologies provide features not previously available in needleless valve technology that provide greater patient care. |
|
|
|
|
|
